Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis

A. He; T. Spelman; V. Jokubaitis; A. Lugaresi; G. Izquierdo; M. Trojano; P. Grammond; J. Lechner-Scott; P. Duquette; M. Girard; E. Pucci; M. Slee; F. Grand'Maison; C. Oreja-Guevara; C. Boz; R. Fernandez-Bolaños; S. Hodgkinson; J. Sanchez-Menoyo; G. Iuliano; M. Barnett; F. Moore; H. Butzkueven; T. Kalincik; MSBase Study Group

doi:10.1177/1352458514546077

Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis

A. He
, T. Spelman
, V. Jokubaitis
, A. Lugaresi
, G. Izquierdo
, M. Trojano
, P. Grammond
, J. Lechner-Scott
, P. Duquette
, M. Girard
, E. Pucci
, M. Slee
, F. Grand'Maison
, C. Oreja-Guevara
, C. Boz
, R. Fernandez-Bolaños
, S. Hodgkinson
, J. Sanchez-Menoyo
, G. Iuliano
, M. Barnett

F. Moore, H. Butzkueven, T. Kalincik, MSBase Study Group

College of Medicine and Public Health

Research output: Contribution to journal › Meeting Abstract › peer-review

8 Citations (Scopus)

32 Downloads (Pure)

Original language	English
Pages (from-to)	193
Number of pages	1
Journal	Multiple Sclerosis
Volume	20
Issue number	1 Suppl.
DOIs	https://doi.org/10.1177/1352458514546077
Publication status	Published - Sept 2014

Access to Document

10.1177/1352458514546077Licence: CC BY-NC

Final published versionFinal published version, 80.3 KBLicence: CC BY-NC

Cite this

He, A., Spelman, T., Jokubaitis, V., Lugaresi, A., Izquierdo, G., Trojano, M., Grammond, P., Lechner-Scott, J., Duquette, P., Girard, M., Pucci, E., Slee, M., Grand'Maison, F., Oreja-Guevara, C., Boz, C., Fernandez-Bolaños, R., Hodgkinson, S., Sanchez-Menoyo, J., Iuliano, G., ... MSBase Study Group (2014). Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis. Multiple Sclerosis, 20(1 Suppl.), 193. https://doi.org/10.1177/1352458514546077

@article{3040973f69ee4a3aa0e280edba3767de,

title = "Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis",

author = "A. He and T. Spelman and V. Jokubaitis and A. Lugaresi and G. Izquierdo and M. Trojano and P. Grammond and J. Lechner-Scott and P. Duquette and M. Girard and E. Pucci and M. Slee and F. Grand'Maison and C. Oreja-Guevara and C. Boz and R. Fernandez-Bola{\~n}os and S. Hodgkinson and J. Sanchez-Menoyo and G. Iuliano and M. Barnett and F. Moore and H. Butzkueven and T. Kalincik and \{MSBase Study Group\}",

year = "2014",

month = sep,

doi = "10.1177/1352458514546077",

language = "English",

volume = "20",

pages = "193",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "1 Suppl.",

}

He, A, Spelman, T, Jokubaitis, V, Lugaresi, A, Izquierdo, G, Trojano, M, Grammond, P, Lechner-Scott, J, Duquette, P, Girard, M, Pucci, E, Slee, M, Grand'Maison, F, Oreja-Guevara, C, Boz, C, Fernandez-Bolaños, R, Hodgkinson, S, Sanchez-Menoyo, J, Iuliano, G, Barnett, M, Moore, F, Butzkueven, H, Kalincik, T & MSBase Study Group 2014, 'Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis', Multiple Sclerosis, vol. 20, no. 1 Suppl., pp. 193. https://doi.org/10.1177/1352458514546077

TY - JOUR

T1 - Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis

AU - He, A.

AU - Spelman, T.

AU - Jokubaitis, V.

AU - Lugaresi, A.

AU - Izquierdo, G.

AU - Trojano, M.

AU - Grammond, P.

AU - Lechner-Scott, J.

AU - Duquette, P.

AU - Girard, M.

AU - Pucci, E.

AU - Slee, M.

AU - Grand'Maison, F.

AU - Oreja-Guevara, C.

AU - Boz, C.

AU - Fernandez-Bolaños, R.

AU - Hodgkinson, S.

AU - Sanchez-Menoyo, J.

AU - Iuliano, G.

AU - Barnett, M.

AU - Moore, F.

AU - Butzkueven, H.

AU - Kalincik, T.

AU - MSBase Study Group

PY - 2014/9

Y1 - 2014/9

U2 - 10.1177/1352458514546077

DO - 10.1177/1352458514546077

M3 - Meeting Abstract

SN - 1352-4585

VL - 20

SP - 193

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 1 Suppl.

ER -